The Utility of Contrast-Enhanced Ultrasound (CEUS) in Assessing the Risk of Malignancy in Thyroid Nodules

Agnieszka Żyłka,Katarzyna Dobruch-Sobczak,Hanna Piotrzkowska-Wróblewska,Maciej Jędrzejczyk,Elwira Bakuła-Zalewska,Piotr Góralski,Jacek Gałczyński,Marek Dedecjus
DOI: https://doi.org/10.3390/cancers16101911
2024-05-18
Cancers
Abstract:Background: Ultrasonography is a primary method used in the evaluation of thyroid nodules, but no single feature of this method predicts malignancy with high accuracy. Therefore, this paper aims to assess the utility of contrast-enhanced ultrasound (CEUS) in the differential diagnosis of thyroid nodules. Methods: The study group comprised 188 adult patients (155 women and 33 men) who preoperatively underwent CEUS of a thyroid nodule classified as Bethesda categories II–VI after fine-needle aspiration biopsy. During the CEUS examination, 1.5 mL of SonoVue contrast was injected intravenously, after which 15 qualitative CEUS enhancement patterns were analysed. Results: The histopathologic results comprised 65 benign thyroid nodules and 123 thyroid carcinomas. The dominant malignant CEUS features, such as hypo- and heterogeneous enhancement and slow wash-in phase, were evaluated, whereas high enhancement, ring enhancement, and a slow wash-out phase were assessed as predictors of benign lesions. Two significant combinations of B-mode and CEUS patterns were noted, namely, hypoechogenicity with heterogeneous enhancement and non-smooth margins with hypo- or iso-enhancement. Conclusions: The preliminary results indicate that CEUS is a useful tool in assessing the risk of malignancy of thyroid lesions. The combination of the qualitative enhancement parameters and B-mode sonographic features significantly increases the method's usefulness.
oncology
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to evaluate the application value of contrast - enhanced ultrasound (CEUS) in the assessment of the malignant risk of thyroid nodules. Specifically, the author hopes to improve the accuracy of differentiating benign and malignant thyroid nodules by combining the features of B - mode ultrasound and CEUS. ### Research Background The diagnosis of thyroid nodules mainly depends on ultrasound examination, but a single ultrasound feature cannot accurately predict the malignant risk of nodules. Therefore, researchers introduced CEUS as a new diagnostic tool, hoping to more accurately assess the malignant risk of thyroid nodules through a multi - parameter method (such as the combination of B - mode ultrasound and CEUS features). ### Research Objectives 1. **Evaluate the clinical practicality of CEUS**: The study aims to evaluate the application value of CEUS in differentiating benign and malignant thyroid nodules. 2. **Combine multiple features**: The study explores whether combining B - mode ultrasound features with CEUS features can significantly improve the diagnostic accuracy. 3. **Identify specific CEUS features**: The study also evaluates the effectiveness of certain specific CEUS features (such as hypoenhancement, heterogeneous enhancement, etc.) as predictors of thyroid cancer. ### Main Findings - **CEUS features of malignant nodules**: - Hypoenhancement - Heterogeneous enhancement - Slow wash - in phase - **CEUS features of benign nodules**: - High enhancement - Ring enhancement - Slow wash - out phase ### Conclusion Preliminary results show that CEUS is a useful tool and can significantly improve the accuracy of assessing the malignant risk of thyroid nodules. Especially when combined with B - mode ultrasound features, CEUS can provide more diagnostic information and is helpful for better differentiating benign and malignant thyroid nodules. ### Formula Summary The statistical analysis involved in this paper uses a logistic regression model. Here are some of the key formulas: - **Univariate logistic regression model**: \[ \text{OR} = e^{\beta} \] where \(\text{OR}\) is the Odds Ratio and \(\beta\) is the regression coefficient. - **Multivariate logistic regression model**: \[ \log\left(\frac{p}{1 - p}\right)=\beta_0+\beta_1X_1+\beta_2X_2+\cdots+\beta_nX_n \] where \(p\) is the probability of an event occurring, \(\beta_0\) is the intercept, \(\beta_i\) is the regression coefficient of each variable, and \(X_i\) is the independent variable. These formulas are used to evaluate the influence of different features on the malignant risk of thyroid nodules and calculate the corresponding Odds Ratio and its confidence interval.